Bumper Offer - Urjas oil Just @ Rs. 1
Tolvat 30 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Inappropriate Antidiuretic Hormone Secretion.
The right dosage of Tolvat 30 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Tolvat 30 Tablet include Increased thirst, Weakness. Some other side effects of Tolvat 30 Tablet have been listed ahead. Such side effects of Tolvat 30 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Tolvat 30 Tablet's effect during pregnancy is Severe and Severe while nursing. Further, the section on Tolvat 30 Tablet related warnings talks about Tolvat 30 Tablet's effects on the liver, heart and kidney.
Tolvat 30 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease, Hyperkalemia are examples of such conditions.
Besides this, Tolvat 30 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Tolvat 30 Tablet is not safe while driving, and is is not addictive in nature.
Tolvat 30 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tolvat 30 Tablet is used -
Moderate
Mild
Common
Is the use of Tolvat 30 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Tolvat. If you are pregnant, do not take Tolvat without a doctor's advice.
Is the use of Tolvat 30 Tablet safe during breastfeeding?
Tolvat may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Tolvat 30 Tablet on the Kidneys?
Tolvat has very mild side effects on the kidneys.
What is the effect of Tolvat 30 Tablet on the Liver?
Tolvat does not damage the liver.
What is the effect of Tolvat 30 Tablet on the Heart?
Tolvat is not harmful for the heart.
Tolvat 30 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Tolvat 30 Tablet unless your doctor advises you to do so -
Is this Tolvat 30 Tablet habit forming or addictive?
Forming a habit of Tolvat 30 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Tolvat 30 Tablet. So it is best to avoid driving.
Is it safe?
Tolvat 30 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Tolvat 30 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Tolvat 30 Tablet
Some foods when eaten with Tolvat 30 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Tolvat 30 Tablet
Taking alcohol with Tolvat 30 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1216-1217
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 525
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Samsca® (tolvaptan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jynarque (tolvaptan)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1216-1217
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 525
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Samsca® (tolvaptan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jynarque (tolvaptan)
